EIF2AK3 and cancer: Knockdown of PERK sensitizes esophageal and breast tumor cells to chemotherapeutic agents and impairs the growth of these two malignant types of cancer in vitro, which is attributed to the activation of the double stranded DNA breakage checkpoint to trigger G2/M arrest and the accumulation of ROS (Fig. 3) (123).